William K. Schmidt
Chief Tech/Sci/R&D Officer at ENSYSCE BIOSCIENCES, INC.
Profile
William K.
Schmidt is currently the Chief Medical Officer at Signature Therapeutics, Inc., and the Vice President-Clinical & Regulatory at Arcion Therapeutics LLC.
He is also the President of Northstar Consulting Group.
In addition, he holds the position of Chief Medical Officer & SVP-Clinical Development at Ensysce Biosciences, Inc. since 2022.
Previously, Dr. Schmidt worked as the Vice President-Scientific Affairs at Adolor Corp., Vice President-Clinical Research at Renovis, Inc., Vice President-Clinical Development at CrystalGenomics Invites Co., Ltd., Senior Vice President-Development at Limerick BioPharma, Inc., President of The Eastern Pain Association, and Vice President-Clinical Development at CG Pharmaceuticals, Inc.Dr. Schmidt completed his undergraduate studies at the University of California, Berkeley, and obtained his doctorate degree from The University of California, San Francisco.
William K. Schmidt active positions
Companies | Position | Start |
---|---|---|
ENSYSCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
Arcion Therapeutics LLC
Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Chief Tech/Sci/R&D Officer | 2013-01-21 |
Northstar Consulting Group | President | - |
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | - |
Former positions of William K. Schmidt
Companies | Position | End |
---|---|---|
CG Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
CG INVITES CO., LTD. | Corporate Officer/Principal | - |
The Eastern Pain Association
The Eastern Pain Association Miscellaneous Commercial ServicesCommercial Services The Eastern Pain Association operates as health care association which provides pain control services. The company was founded in 1974 by Berthold B. Wolff and is headquartered in Gainesville, FL. | President | - |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Limerick BioPharma is dedicated to the discovery and development of novel small molecule product candidates to address areas of significant unmet medical need. Their intent is to bring forth innovative therapies that have the potential to change treatment paradigms via their enhanced safety and / or efficacy profiles. Limerick is developing novel products that can enhance the safety of existing therapeutic agents or function as innovative stand-alone therapies. Their lead programs are in the areas of metabolic diseases and solid organ transplantation. In metabolic diseases, their programs are in clinical development for treatment of diabetes and dyslipidemia. For transplant indications, their programs are in clinical development as adjunctive therapy to treat metabolic dysregulation induced by leading immunosuppressants. Beyond these first-generation programs, Limerick has developed a proprietary and cutting-edge discovery platform that can be leveraged for other high-need, high-value areas. They intend to maximize the value of their product candidates and discovery platform through independent development, licensing and other partnership opportunities. | Corporate Officer/Principal | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Chief Tech/Sci/R&D Officer | - |
Training of William K. Schmidt
The University of California, San Francisco | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ENSYSCE BIOSCIENCES, INC. | Health Technology |
CG INVITES CO., LTD. | Health Technology |
Private companies | 8 |
---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Limerick BioPharma is dedicated to the discovery and development of novel small molecule product candidates to address areas of significant unmet medical need. Their intent is to bring forth innovative therapies that have the potential to change treatment paradigms via their enhanced safety and / or efficacy profiles. Limerick is developing novel products that can enhance the safety of existing therapeutic agents or function as innovative stand-alone therapies. Their lead programs are in the areas of metabolic diseases and solid organ transplantation. In metabolic diseases, their programs are in clinical development for treatment of diabetes and dyslipidemia. For transplant indications, their programs are in clinical development as adjunctive therapy to treat metabolic dysregulation induced by leading immunosuppressants. Beyond these first-generation programs, Limerick has developed a proprietary and cutting-edge discovery platform that can be leveraged for other high-need, high-value areas. They intend to maximize the value of their product candidates and discovery platform through independent development, licensing and other partnership opportunities. | Health Technology |
Arcion Therapeutics LLC
Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Health Technology |
Northstar Consulting Group | |
The Eastern Pain Association
The Eastern Pain Association Miscellaneous Commercial ServicesCommercial Services The Eastern Pain Association operates as health care association which provides pain control services. The company was founded in 1974 by Berthold B. Wolff and is headquartered in Gainesville, FL. | Commercial Services |
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Health Technology |
CG Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- William K. Schmidt